Está disponible para descarga el artículo sobre Diagnosis and Management of Thyroid Disease during Pregnancy and the Postpartum, de la Asociación Americana de Tiroides.
Publicaciones Similares
Evolocumab and Clinical Outcomes in Patients with Card. Disease
PorSadenoDescargue el artículo completo ABSTRACT BACKGROUND Evolocumab is a monoclonal antibody that inhibits proprotein convertase subtilisin–kexin type 9 (PCSK9) and lowers low-density lipoprotein (LDL) cholesterol levels by approximately 60%. Whether it prevents cardiovascular events is uncertain. METHODS We conducted a randomized, double-blind, placebo-controlled trial involving 27,564 patients with atherosclerotic cardiovascular disease and LDL cholesterol levels…
Rueda por la Diabetes al Mont Blanc, con el Doctor Delgado
PorSadenoEl Doctor Elías Delgado, coordinador de Diabetes del Servicio de Endocrino del HUCA, participó el pasado mes de septiembre en el programa ‘Rueda por la Diabetes al Mont Blanc’, una ruta en bicicleta de montaña con personas con Diabetes Mellitus Tipo 1. El Doctor Delgado cuenta su experiencia en este post: El Tour del…
Artículo Monitorización Glod
PorSadenoYa está disponible para su consulta el artículo Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections. The GOLD Randomized Clinical Trial Descárgalo aquí
Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial
PorSadenoConsulta aquí el artículo: Efficacy and safety of alirocumab in insulin-treated patients with type 1 or type 2 diabetes and high cardiovascular risk: Rationale and design of the ODYSSEY DM–INSULIN trial
Evidencias de los nuevos tratamientos para el colesterol
PorSadenoClinical efficacy and safety of achieving very low LDL-cholesterol concentrations with the PCSK9 inhibitor evolocumab: a prespecified secondary analysis of the FOURIER trial LDL cholesterol is a well established risk factor for atherosclerotic cardiovascular disease. How much one should or safely can lower this risk factor remains debated. We aimed to explore the relationship between progressively lower…
Guía Dislipemias 2016
PorSadenoDescárgate aquí la Guía Dislipemias 2016
